Mednax’s NEO: The Conference for Neonatology Goes Virtual Feb. 15-19
January 26 2021 - 6:45AM
Business Wire
Premier neonatology meeting moves to a new
virtual format, continuing its longstanding tradition of addressing
the latest topics in neonatal management to improve newborn
outcomes
Mednax, Inc. (NYSE: MD), the national health solutions partner
specializing in prenatal, neonatal and pediatric services, will
host NEO: The Conference for Neonatology Feb. 15-19. NEO is
recognized as one of the top neonatology meetings in the U.S. Now
in its 42nd year, the 2021 event will take place via an interactive
virtual platform, offering a unique opportunity to engage and
network with peers while continuing its longstanding tradition of
providing the latest information on key areas of neonatal
management to improve newborn outcomes.
NEO is co-directed by Reese Clark, M.D., Vice President of
Clinical Research for the Mednax Center for Research, Education,
Quality and Safety (CREQS), and Timothy Biela, M.D.,
Mednax-affiliated neonatologist at Pediatrix Medical Group of Texas
– San Antonio. Drs. Clark and Biela have assembled an esteemed
panel of speakers comprised of well-recognized faculty from top
institutions across the country as well as several
Mednax-affiliated physicians. The group will address critical and
controversial issues that influence the clinical practice of
newborn medicine today, including a session on COVID-19 preparation
in the NICU. All attendees will have on-demand access to live
presentations 30 days following the event, until March 24.
This year’s Legends of Neonatology Award will be presented to
Robert Christensen, M.D., of the University of Utah School of
Medicine. The Legends of Neonatology Hall of Fame, established in
2007, honors the remarkable individuals whose clinical
contributions have helped forge new ground in neonatal medicine.
Dr. Christensen has served as a mentor to hundreds of students,
residents and fellows throughout their research careers. His
landmark work has been in the field of neonatal hematology and the
treatment of hematological disorders. Many of the protocols used
today to define blood cell abnormalities in newborn infants were
established by Dr. Christensen.
The Mednax CREQS is accredited with commendation as a provider
of continuing medical education by the Accreditation Council for
Continuing Medical Education and as a provider of continuing
nursing education by the American Nurses Credentialing Center’s
Commission on Accreditation. NEO participants can earn up to 19.0
AMA PRA Category 1 Credits™ and nursing contact hour(s).
For more information and to register, visit NEO online.
ABOUT MEDNAX
Mednax, Inc. is a comprehensive national medical group
specializing in prenatal, neonatal and pediatric services.
Physicians and advanced practitioners practicing as part of Mednax
are reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, clinical research,
education, continuous quality improvement and safety initiatives
and telemedicine to enhance patient outcomes and provide
high-quality, cost-effective care. The Company was founded in 1979,
and today, through its affiliated medical groups and practices,
Mednax provides services through a network of more than 3,500
clinicians in 41 states, Puerto Rico and the U.S. Virgin Islands.
Additional information is available at www.mednax.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210126005450/en/
Jennifer Gutierrez Sr. Communications Specialist 954-384-0175
ext. 5684 jennifer_gutierrez@mednax.com
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Apr 2023 to Apr 2024